NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.

TitleNF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
Publication TypeJournal Article
Year of Publication2003
AuthorsHatada EN, Do RKG, Orlofsky A, Liou H-chi, Prystowsky M, Maclennan ICM, Caamano J, Chen-Kiang S
JournalJ Immunol
Volume171
Issue2
Pagination761-8
Date Published2003 Jul 15
ISSN0022-1767
KeywordsAnimals, Apoptosis, B-Cell Activating Factor, B-Lymphocyte Subsets, bcl-X Protein, Cell Differentiation, Cell Survival, I-kappa B Proteins, Interphase, Membrane Proteins, Mice, Mice, Inbred C57BL, Mice, Knockout, Minor Histocompatibility Antigens, NF-kappa B, NF-kappa B p50 Subunit, NF-kappa B p52 Subunit, NF-KappaB Inhibitor alpha, Phosphorylation, Protein Biosynthesis, Protein Processing, Post-Translational, Proto-Oncogene Proteins c-bcl-2, Signal Transduction, Transcription Factor RelA, Tumor Necrosis Factor-alpha, Up-Regulation
Abstract

B lymphocyte stimulator (BLyS), a TNF family protein essential for peripheral B cell development, functions primarily through attenuation of B cell apoptosis. In this study, we show that BLyS activates NF-kappaB through both classical and alternative pathways with distinct kinetics in quiescent mature B cells. It rapidly and transiently enhances the p50/p65 DNA binding activity and induces phosphorylation of IkappaBalpha characteristic of the classical NF-kappaB pathway, albeit maintaining IkappaBalpha at a constant level through ongoing protein synthesis and proteasome-mediated destruction. With delayed kinetics, BLyS promotes the processing of p100 to p52 and sustained formation of p52/RelB complexes via the alternative NF-kappaB pathway. p50 is dispensable for p100 processing. However, it is required to mediate the initial BLyS survival signals and concomitant activation of Bcl-x(L) in quiescent mature B cells ex vivo. Although also a target of BLyS activation, at least one of the A1 genes, A1-a, is dispensable for the BLyS survival function. These results suggest that BLyS mediates its survival signals in metabolically restricted quiescent B cells, at least in part, through coordinated activation of both NF-kappaB pathways and selective downstream antiapoptotic genes.

DOI10.4049/jimmunol.171.2.761
Alternate JournalJ Immunol
PubMed ID12847243
Grant ListAR49436 / AR / NIAMS NIH HHS / United States
CA80204 / CA / NCI NIH HHS / United States
GM07739 / GM / NIGMS NIH HHS / United States
Related Lab: 
Related Faculty: 
Selina Chen-Kiang, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700